-Kiyohito Terada Researcher Activity Profile

Research Author Detailed Information 

Kiyohito Terada Publication Rate By Year

Kiyohito Terada has published 6 paper(s) in 2007, for a total of 6 research publications in total.

Kiyohito K Terada Author Information

LAST NAME: terada

FIRST NAME: kiyohito

INITIALS: K

AFFILIATION:

Papers

Kiyohito Terada's Publication Record

1. Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB. Year Published: 2007
Department of Neurology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaharacho, Sakyoku, Kyoto, 606-8507, Japan.
2. Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB. Year Published: 2007
Department of Neurology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaharacho, Sakyoku, Kyoto, 606-8507, Japan.
3. Bilateral symmetric tonic posturing suggesting propagation to the supplementary motor area in a patient with precuneate cortical dysplasia. Year Published: 2007
Department of Neurological Surgery.
4. Intracranial EEG findings in patients with lesional lateral temporal lobe epilepsy. Year Published: 2007
National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Urushiyama 886, Shizuoka 420-8688, Japan.
5. Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB. Year Published: 2007
Department of Neurology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaharacho, Sakyoku, Kyoto, 606-8507, Japan.
6. Bilateral symmetric tonic posturing suggesting propagation to the supplementary motor area in a patient with precuneate cortical dysplasia. Year Published: 2007
Department of Neurological Surgery, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan. umesh@szec.hosp.go.jp